As part of the Children's Oncology Group (COG), members of the Pediatric Hematology and Oncology Program work cooperatively with other academic health centers to conduct large-scale investigations. Because childhood cancer is relatively rare, medical centers must work together to compile enough data to yield reliable science. Our participation also assures that our patients have access to the newest and best treatments available. Efforts such as these over the last 60 years have yielded dramatic increases in cure rates of pediatric cancers, such as lymphocytic leukemia in which 80 percent of children are cured.

With the establishment of Yale's Comprehensive Hemophilia and Blood Clotting clinic, our program has become unparalleled in the timely diagnosis of bleeding and clotting disorders, allowing for life-saving therapy.

Learn more about the Yale Pediatric Hematology and Oncology Program and its cutting-edge research.